Physician

Anthony Vincent Petrosini, MD

According to 2025 Medicare claims, Anthony Petrosini, MD (NPI: 1962481499) practices sports medicine in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is ORTHONJ LLC (NPI: 1720557432; TIN: 824413259) and primary practice location at 08736-1444.

Petrosini's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 145 traditional Medicare patients, billed 1,242 HCPCS/CPT codes, and received $33,136 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 90 prescription claims across 65 beneficiaries totaling $418 in drug costs, led by Naproxen (Naproxen). Open Payments data shows 23 records totaling $1,841. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $54,688 to $33,136. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,289 and ending at $418. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$27K$55K2015 Medicare payment: $54,688 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $47,852 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $46,731 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $42,056 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $34,491 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $22,381 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $38,606 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $41,133 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $41,084 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $33,136 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153171,892$54,688
20163821,630$47,852
20173921,832$46,731
20183861,638$42,056
20192341,957$34,491
20201901,395$22,381
20213261,628$38,606
20223121,592$41,133
20231971,386$41,084
20241451,242$33,136

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.3K$6.6K2015 Drug cost: $1,289 (USD; Tot_Drug_Cst)2016 Drug cost: $704 (USD; Tot_Drug_Cst)2017 Drug cost: $6,559 (USD; Tot_Drug_Cst)2018 Drug cost: $2,569 (USD; Tot_Drug_Cst)2019 Drug cost: $343 (USD; Tot_Drug_Cst)2020 Drug cost: $286 (USD; Tot_Drug_Cst)2021 Drug cost: $246 (USD; Tot_Drug_Cst)2022 Drug cost: $339 (USD; Tot_Drug_Cst)2023 Drug cost: $333 (USD; Tot_Drug_Cst)2024 Drug cost: $418 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154778$1,289
20163652$704
20176194$6,559
20182642$2,569
20193038$343
20202636$286
20213338$246
20223338$339
20235878$333
20246590$418

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4761$96
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more80107$66
20610Aspiration and/or injection of fluid from large joint5569$48
73030X-ray of shoulder, minimum of 2 views6068$25
J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg62616$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
NaproxenNaproxen43640$170
MethylprednisoloneMethylprednisolone18109$108
MeloxicamMeloxicam14405$53

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.21$1,841Zimmer Biomet Holdings, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.2$75,000Centinel Spine, LLC

FAQ

What Medicare data is available for Anthony Vincent Petrosini, MD?

Tedicare shows public-source Medicare data for Anthony Vincent Petrosini, MD (NPI 1962481499), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anthony Vincent Petrosini, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anthony Vincent Petrosini, MD?

Anthony Vincent Petrosini, MD is linked to ORTHONJ LLC (billing NPI 1720557432) in the available physician profile data.

Does Anthony Vincent Petrosini, MD have Open Payments data?

Anthony Vincent Petrosini, MD has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.